Richard Paul Santarosa, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 166 W Broad St, Suite 404, Stamford, CT 06902 Phone: 203-356-9391 Fax: 203-356-0270 |
Dr. Hugh Joseph Lavery Iii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 29 Hospital Plz Ste 604, Stamford, CT 06902 Phone: 203-276-8545 Fax: 203-276-8572 |
Dr. Michael J Nurzia, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 80 Mill River St, Suite 404, Stamford, CT 06902 Phone: 203-356-9391 |
Dr. Conner C Brown, M.D. Urology Medicare: Medicare Enrolled Practice Location: 29 Hospital Plz Ste 604, Stamford, CT 06902 Phone: 203-276-8545 Fax: 203-276-8572 |
Rudy T Andriani, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 166 W Broad St, Suite 404, Stamford, CT 06902 Phone: 203-356-9692 Fax: 203-356-0270 |
Dr. Jonathan A Waxberg, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 35 Hoyt St, Stamford, CT 06905 Phone: 203-324-2268 Fax: 203-324-4866 |
News Archive
Senate President Therese Murray, the Massachusetts Life Sciences Center, the Howard Hughes Medical Institute (HHMI), and key state officials gathered at the Marine Biological Laboratory (MBL) today to break ground on a $25 million renovation of the MBL's central research training facility, the Loeb Laboratory.
Heart failure is associated with a 30 percent increase in major fractures and also identifies a high-risk population that may benefit from increased screening and treatment for osteoporosis, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
A Washington Post-ABC News poll finds President Barack Obama's disapproval reaches an all-time high. The fallout from the beleaguered rollout of healthcare.gov also seems to be shaping voters' thoughts about upcoming congressional races.
ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality-of-life for sufferers of articular cartilage injuries, today announced that patient enrollment in the Company's Phase II study of the BioCartâ„¢ Autologous Cartilage System is nearing the halfway point and is expected to be completed within the next three months.
Planned Parenthood of Arizona will not appeal a state-court ruling that allows this 2009 measure to take effect.
› Verified 3 days ago